Compare DVAX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | STAA |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2004 | N/A |
| Metric | DVAX | STAA |
|---|---|---|
| Price | $10.94 | $25.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 8 |
| Target Price | ★ $26.50 | $22.50 |
| AVG Volume (30 Days) | ★ 1.7M | 762.7K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $330,514,000.00 | $230,591,000.00 |
| Revenue This Year | $24.63 | N/A |
| Revenue Next Year | $15.85 | $22.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 26.73 | N/A |
| 52 Week Low | $9.20 | $13.50 |
| 52 Week High | $14.63 | $30.81 |
| Indicator | DVAX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 44.70 |
| Support Level | $10.79 | $25.55 |
| Resistance Level | $11.10 | $26.93 |
| Average True Range (ATR) | 0.31 | 0.92 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 30.00 | 3.75 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.